Biosecure Act Tailwind: Why India’s CDMO Pharma Players Are Back in Focus?
India’s Contract Development and Manufacturing Organisation (CDMO) sector is once again gaining strong investor attention, supported by global supply-chain diversification, competitive cost structures, and favourable policy momentum. As the US moves ahead with the Biosecure Act, companies with hi...
Easy & quick